Łukasz Przykaza

Łukasz Przykaza

Auto-generated profile, based on publicly available information

Łukasz Przykaza

Polish Acad Sci, Mossakowski Med Res Inst, Lab Preclin Res & Environm Agents, A Pawinski Str 5, PL-02106 Warsaw, Poland

Research Focus & Metrics

Academic Career Length

16Years (2011-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
15 November 2021 in Frontiers in Immunology
Verified
Journal Article
Open access
ŁPŁukasz Przykaza
Łukasz Przykaza
Despite the enormous progress in the understanding of the course of the ischemic stroke over the last few decades, a therapy that effectively protects neurovascular units (NVUs) and significantly improves neurological functions in stroke patients has still not been achieved. The reasons for this state are unclear, but it is obvious that the cerebral ischemia and reperfusion cascade is a highly complex phenomenon, which includes the intense neuroinflammatory processes, and comorbid stroke risk factors strongly worsen stroke outcomes and likely make a substantial contribution to the pathophysiology of the ischemia/reperfusion, enhancing difficulties in searching of successful treatment. Common concomitant stroke risk factors (arterial hypertension, diabetes mellitus and hyperlipidemia) strongly drive inflammatory processes during cerebral ischemia/reperfusion; because these factors are often present for a long time before a stroke, causing low-grade background inflammation in the brain, and already initially disrupting the proper functions of NVUs. Broad consideration of this situation in basic research may prove to be crucial for the success of future clinical trials of neuroprotection, vasculoprotection and immunomodulation in stroke. This review focuses on the mechanism by which coexisting common risk factors for stroke intertwine in cerebral ischemic/reperfusion cascade and the dysfunction and disintegration of NVUs through inflammatory processes, principally activation of pattern recognition receptors, alterations in the expression of adhesion molecules and the subsequent pathophysiological consequences.


1 March 2016 in Neuropharmacology
Verified
Journal Article
Closed access
HDHelena Domin
Helena Domin
ŁPŁukasz Przykaza
Łukasz Przykaza
DJDanuta Jantas
Danuta Jantas
EKEwa Koźniewska-Kołodziejska
Ewa Koźniewska-Kołodziejska
PBPaweł M. Boguszewski
Paweł M. Boguszewski
MŚMaria Śmiałowska
Maria Śmiałowska

1 June 2018 in Progress in Neuro-Psychopharmacology and Biological Psychiatry
Verified
Journal Article
Closed access
HDHelena Domin
Helena Domin
ŁPŁukasz Przykaza
Łukasz Przykaza
EKEwa Koźniewska-Kołodziejska
Ewa Koźniewska-Kołodziejska
PBPaweł M. Boguszewski
Paweł M. Boguszewski
MŚMaria Śmiałowska
Maria Śmiałowska

1 March 2017 in Neuroscience
Verified
Journal Article
Closed access
HDHelena Domin
Helena Domin
ŁPŁukasz Przykaza
Łukasz Przykaza
DJDanuta Jantas
Danuta Jantas
EKEwa Koźniewska-Kołodziejska
Ewa Koźniewska-Kołodziejska
PBPaweł M. Boguszewski
Paweł M. Boguszewski
MŚMaria Śmiałowska
Maria Śmiałowska

19 October 2024 in Neuroscience
Verified
Journal Article
Closed access
ŁPŁukasz Przykaza
Łukasz Przykaza
HDHelena Domin
Helena Domin
MŚMaria Śmiałowska
Maria Śmiałowska
LSLuiza Stanaszek
Luiza Stanaszek
PBPaweł M. Boguszewski
Paweł M. Boguszewski
EKEwa Koźniewska-Kołodziejska
Ewa Koźniewska-Kołodziejska